International Immunology, Vol. 7, No. 3, pp. 415-423,March 1995
© 1995 Japanese Society for Immunology
Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential
MRC Lymphocyte Development Group, MRC Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital Du Cane Road, London W12 0NN, UK
1 Laboratoire de Génétique Molèculaire des Eucaryotes, CNRS, Institut de Chimie Biologique, Faculté de Médecine 11 rue Humann, 67085 Strasbourg Cedex, France
2 Department of Immunology, University of Birmingham Medical School Vincent Drive, Edgbaston, Birmingham B15 2TJ, UK
Correspondence to: Correspondence to: A. G. Fisher
Transgenic mice carrying the murine IL-7 gene under the MHC class II (E
) promoter are described which develop lymphoid tumours at a high incidence when maintained in conventional or specific pathogen-free environments. Cells obtained from the lesions were relatively monomorphic, expressed a variety of B cell associated markers (BP-1, B220, CD43) but lacked surface Ig. Some mice showed expanded populations of cells phenotypically similar to the recently reported bipotent B/macrophage stem cell subset (AA4.1high, B220–, Ig–) which could be cloned and maintained in vitro. These cells expressed IL-7 receptors, proliferated in response to IL-7 and in most cases had germllne configuration of the Ig heavy chain locus. Cell lines cloned from two such tumours generated macrophages spontaneously in culture, consistent with their bipotent B cell/macrophage phenotype. These results suggest that IL-7 plays a role in very early stages of B cell ontogeny prior to bona fide B cell commitment.
Keywords: B cell, IL-7, lymphoproliferative disorder, macrophage
Received 6 September 1994, accepted 18 November 1994.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Malaspina, S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T.-W. Chun, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 PNAS, February 14, 2006; 103(7): 2262 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pellegrini, P. Bouillet, M. Robati, G. T. Belz, G. M. Davey, and A. Strasser Loss of Bim Increases T Cell Production and Function in Interleukin 7 Receptor-deficient Mice J. Exp. Med., November 1, 2004; 200(9): 1189 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Storek, T. Gillespy III, H. Lu, A. Joseph, M. A. Dawson, M. Gough, J. Morris, R. C. Hackman, P. A. Horn, G. E. Sale, et al. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys Blood, May 15, 2003; 101(10): 4209 - 4218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Scripture-Adams, D. G. Brooks, Y. D. Korin, and J. A. Zack Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype J. Virol., November 13, 2002; 76(24): 13077 - 13082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Fry and C. L. Mackall Interleukin-7: from bench to clinic Blood, May 13, 2002; 99(11): 3892 - 3904. [Full Text] [PDF] |
||||
![]() |
T. J. Fry, E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, et al. A potential role for interleukin-7 in T-cell homeostasis Blood, May 15, 2001; 97(10): 2983 - 2990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banerjee and P. Rothman IL-7 Reconstitutes Multiple Aspects of v-Abl-Mediated Signaling J. Immunol., November 1, 1998; 161(9): 4611 - 4617. [Abstract] [Full Text] [PDF] |
||||




